Prosecution Insights
Prosecution Insights
10 pending office actions • 9 art units • 10 examiners • 1 of 10 (10%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| §102 only | 1 (10%) |
| §112 only | 1 (10%) |
| No statute on record | 2 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCHARCZK, JED A | 1 | 80.2% | +15.6% |
| HEIN, DEVIN C | 1 | 45.8% | +29.9% |
| SASAN, ARADHANA | 1 | 64.4% | +26.4% |
| DAHLIN, HEATHER RAQUEL | 1 | 46.5% | +48.9% |
| SHOWALTER, ALEXANDER KEITH | 1 | 52.1% | +53.0% |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.6% | +52.8% |
| WILSON, MICHAEL C | 1 | 41.7% | +17.6% |
| GERIDO, DWAN A | 1 | 57.7% | +30.9% |
| BARSKY, JARED | 1 | 50.2% | +23.0% |
| LANDAU, SHARMILA GOLLAMUDI | 1 | 9.3% | +3.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | LANDAU, SHARMILA GOLLAMUDI | 142d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042503 | CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND | SHOWALTER, ALEXANDER KEITH | 60d overdue |
| 19220457 | METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS | KUCHARCZK, JED A | 46d overdue |
| 18023211 | KAEMPFEROL AGLYCONE-CONTAINING EXTRACT | DAHLIN, HEATHER RAQUEL | 37d overdue |
| 18683025 | INFORMATION PROVISION METHOD FOR PREDICTING HEALTH CONDITION OF CONSUMER AND SUPPORTING HEALTH MAINTENANCE AND IMPROVEMENT | HEIN, DEVIN C | 35d overdue |
| 17762481 | DETECTION METHOD AND DETECTION DEVICE | GERIDO, DWAN A | 17d overdue |
| 18006969 | BLADDER ORGANOID AND METHOD FOR PRODUCING SAME | WILSON, MICHAEL C | 15d overdue |
| 18042167 | BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS | KAPUSHOC, STEPHEN THOMAS | 19d |
| 17397911 | AMELIORATING AGENT FOR FEMALE-SPECIFIC PHYSICAL AND/OR MENTAL UNPLEASANT SYMPTOM | BARSKY, JARED | 22d |
| Art Unit | Apps |
|---|---|
| 1629 | 2 |
| 1623 | 1 |
| 3686 | 1 |
| 1615 | 1 |
| 1683 | 1 |
| 1638 | 1 |
| 1797 | 1 |
| 1628 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19220457 | METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS | KUCHARCZK, JED A | 1623 | Other | Non-Final OA | 46d overdue | AI Ready | May 28, 2025 |
| 18683025 | INFORMATION PROVISION METHOD FOR PREDICTING HEALTH CONDITION OF CONSUMER AND SUPPORTING HEALTH MAINTENANCE AND IMPROVEMENT | HEIN, DEVIN C | 3686 | §103 | Non-Final OA | 35d overdue | Pending | Feb 12, 2024 |
| 18546602 | AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM | SASAN, ARADHANA | 1615 | §103 | Final Rejection | 26d | Pending | Aug 16, 2023 |
| 18023211 | KAEMPFEROL AGLYCONE-CONTAINING EXTRACT | DAHLIN, HEATHER RAQUEL | 1629 | §102 | Non-Final OA | 37d overdue | Pending | Feb 24, 2023 |
| 18042503 | CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND | SHOWALTER, ALEXANDER KEITH | 1629 | Other | Final Rejection | 60d overdue | Pending | Feb 22, 2023 |
| 18042167 | BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS | KAPUSHOC, STEPHEN THOMAS | 1683 | §103 | Non-Final OA | 19d | Pending | Feb 17, 2023 |
| 18006969 | BLADDER ORGANOID AND METHOD FOR PRODUCING SAME | WILSON, MICHAEL C | 1638 | §112 | Non-Final OA | 15d overdue | Pending | Jan 26, 2023 |
| 17762481 | DETECTION METHOD AND DETECTION DEVICE | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 17d overdue | Pending | Mar 22, 2022 |
| 17397911 | AMELIORATING AGENT FOR FEMALE-SPECIFIC PHYSICAL AND/OR MENTAL UNPLEASANT SYMPTOM | BARSKY, JARED | 1628 | §103 | Non-Final OA | 22d | Pending | Aug 09, 2021 |
| 16863187 | EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103 | Final Rejection | 142d overdue | Pending | Apr 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial